These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38214677)

  • 1. A double-blind, randomised, placebo-controlled trial of the coronary sinus Reducer in refractory angina: design and rationale of the ORBITA-COSMIC trial.
    Foley MJ; Rajkumar CA; Ahmed-Jushuf F; Simader F; Pathimagaraj RH; Nijjer S; Sen S; Petraco R; Clesham G; Johnson T; Harrell FE; Kellman P; Francis D; Shun-Shin M; Howard J; Cole GD; Al-Lamee R
    EuroIntervention; 2024 Feb; 20(3):e216-e223. PubMed ID: 38214677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial.
    Foley MJ; Rajkumar CA; Ahmed-Jushuf F; Simader FA; Chotai S; Pathimagaraj RH; Mohsin M; Salih A; Wang D; Dixit P; Davies JR; Keeble TR; Cosgrove C; Spratt JC; O'Kane PD; De Silva R; Hill JM; Nijjer SS; Sen S; Petraco R; Mikhail GW; Khamis R; Kotecha T; Harrell FE; Kellman P; Francis DP; Howard JP; Cole GD; Shun-Shin MJ; Al-Lamee RK
    Lancet; 2024 Apr; 403(10436):1543-1553. PubMed ID: 38604209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind randomised placebo-controlled trial of percutaneous coronary intervention for the relief of stable angina without antianginal medications: design and rationale of the ORBITA-2 trial.
    Nowbar AN; Rajkumar C; Foley M; Ahmed-Jushuf F; Howard JP; Seligman H; Petraco R; Sen S; Nijjer SS; Shun-Shin MJ; Keeble TR; Sohaib A; Collier D; McVeigh P; Harrell FE; Francis DP; Al-Lamee RK
    EuroIntervention; 2022 Apr; 17(18):1490-1497. PubMed ID: 35156616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II, sham-controlled, double-blinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: study protocol for a randomized controlled trial.
    Jolicœur EM; Banai S; Henry TD; Schwartz M; Doucet S; White CJ; Edelman E; Verheye S
    Trials; 2013 Feb; 14():46. PubMed ID: 23413981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease.
    Al-Lamee R; Howard JP; Shun-Shin MJ; Thompson D; Dehbi HM; Sen S; Nijjer S; Petraco R; Davies J; Keeble T; Tang K; Malik IS; Cook C; Ahmad Y; Sharp ASP; Gerber R; Baker C; Kaprielian R; Talwar S; Assomull R; Cole G; Keenan NG; Kanaganayagam G; Sehmi J; Wensel R; Harrell FE; Mayet J; Thom SA; Davies JE; Francis DP
    Circulation; 2018 Oct; 138(17):1780-1792. PubMed ID: 29789302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.
    Al-Lamee R; Thompson D; Dehbi HM; Sen S; Tang K; Davies J; Keeble T; Mielewczik M; Kaprielian R; Malik IS; Nijjer SS; Petraco R; Cook C; Ahmad Y; Howard J; Baker C; Sharp A; Gerber R; Talwar S; Assomull R; Mayet J; Wensel R; Collier D; Shun-Shin M; Thom SA; Davies JE; Francis DP;
    Lancet; 2018 Jan; 391(10115):31-40. PubMed ID: 29103656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel method to interpret early phase trials shows how the narrowing of the coronary sinus concordantly improves symptoms, functional status and quality of life in refractory angina.
    Jolicoeur EM; Verheye S; Henry TD; Joseph L; Doucet S; White CJ; Edelman E; Banai S
    Heart; 2021 Jan; 107(1):41-46. PubMed ID: 32719097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptoms as a Predictor of the Placebo-Controlled Efficacy of PCI in Stable Coronary Artery Disease.
    Simader FA; Rajkumar CA; Foley MJ; Ahmed-Jushuf F; Chotai S; Bual N; Khokhar A; Gohar A; Lampadakis I; Ganesananthan S; Pathimagaraj RH; Nowbar A; Davies JR; Keeble TR; O'Kane PD; Haworth P; Routledge H; Kotecha T; Spratt JC; Williams R; Nijjer SS; Sen S; Curzen N; Sinha M; Howard JP; Cole G; Harrell FE; Francis DP; Shun-Shin MJ; Al-Lamee RK;
    J Am Coll Cardiol; 2024 Jul; 84(1):13-24. PubMed ID: 38759906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of Life Assessment in Trials of Revascularization for Chronic Stable Angina: Insights from ORBITA and the Implications of Blinding.
    Nowbar AN; Francis DP; Al-Lamee RK
    Cardiovasc Drugs Ther; 2022 Oct; 36(5):1011-1018. PubMed ID: 34417901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiopulmonary exercise testing and efficacy of percutaneous coronary intervention: a substudy of the ORBITA trial.
    Ganesananthan S; Rajkumar CA; Foley M; Thompson D; Nowbar AN; Seligman H; Petraco R; Sen S; Nijjer S; Thom SA; Wensel R; Davies J; Francis D; Shun-Shin M; Howard J; Al-Lamee R
    Eur Heart J; 2022 Sep; 43(33):3132-3145. PubMed ID: 35639660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dobutamine Stress Echocardiography Ischemia as a Predictor of the Placebo-Controlled Efficacy of Percutaneous Coronary Intervention in Stable Coronary Artery Disease: The Stress Echocardiography-Stratified Analysis of ORBITA.
    Al-Lamee RK; Shun-Shin MJ; Howard JP; Nowbar AN; Rajkumar C; Thompson D; Sen S; Nijjer S; Petraco R; Davies J; Keeble T; Tang K; Malik I; Bual N; Cook C; Ahmad Y; Seligman H; Sharp ASP; Gerber R; Talwar S; Assomull R; Cole G; Keenan NG; Kanaganayagam G; Sehmi J; Wensel R; Harrell FE; Mayet J; Thom S; Davies JE; Francis DP
    Circulation; 2019 Dec; 140(24):1971-1980. PubMed ID: 31707827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of coronary sinus reducer implantation in patients with chronic total occlusion of the right coronary artery.
    Mrak M; Pavšič N; Ponticelli F; Beneduce A; Palmisano A; Guarracini S; Esposito A; Banai S; Žižek D; Giannini F; Bunc M
    Kardiol Pol; 2022; 80(1):25-32. PubMed ID: 34643262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary Sinus Reducer Implantation for the Treatment of Chronic Refractory Angina: A Single-Center Experience.
    Giannini F; Baldetti L; Ponticelli F; Ruparelia N; Mitomo S; Latib A; Montorfano M; Jabbour RJ; Aurelio A; Ferri L; Mangieri A; Regazzoli D; Ancona M; Pagnesi M; Faccini A; Chieffo A; Azzalini L; Carlino M; Colombo A
    JACC Cardiovasc Interv; 2018 Apr; 11(8):784-792. PubMed ID: 29673511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary sinus Reducer device for the treatment of refractory angina: A multicenter initial experience.
    Ferreira Reis J; Brízido C; Madeira S; Ramos R; Almeida M; Cacela D
    Rev Port Cardiol; 2023 May; 42(5):413-420. PubMed ID: 36828185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The coronary sinus reducer: clinical evidence and technical aspects.
    Giannini F; Aurelio A; Jabbour RJ; Ferri L; Colombo A; Latib A
    Expert Rev Cardiovasc Ther; 2017 Jan; 15(1):47-58. PubMed ID: 27935738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina.
    Rajkumar CA; Foley MJ; Ahmed-Jushuf F; Nowbar AN; Simader FA; Davies JR; O'Kane PD; Haworth P; Routledge H; Kotecha T; Gamma R; Clesham G; Williams R; Din J; Nijjer SS; Curzen N; Ruparelia N; Sinha M; Dungu JN; Ganesananthan S; Khamis R; Mughal L; Kinnaird T; Petraco R; Spratt JC; Sen S; Sehmi J; Collier DJ; Sohaib A; Keeble TR; Cole GD; Howard JP; Francis DP; Shun-Shin MJ; Al-Lamee RK;
    N Engl J Med; 2023 Dec; 389(25):2319-2330. PubMed ID: 38015442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantation of the coronary sinus reducer for refractory angina due to coronary microvascular dysfunction in the context of apical hypertrophic cardiomyopathy-a case report.
    Cheng K; Keramida G; Baksi AJ; de Silva R
    Eur Heart J Case Rep; 2022 Nov; 6(11):ytac440. PubMed ID: 36415685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary sinus reducer for the treatment of chronic refractory angina pectoris.
    Ponticelli F; Giannini F
    Future Cardiol; 2022 Jul; 18(7):523-537. PubMed ID: 35758146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous coronary intervention versus medical therapy in patients with angina and grey-zone fractional flow reserve values: a randomised clinical trial.
    Hennigan B; Berry C; Collison D; Corcoran D; Eteiba H; Good R; McEntegart M; Watkins S; McClure JD; Mangion K; Ford TJ; Petrie MC; Hood S; Rocchiccioli P; Shaukat A; Lindsay M; Oldroyd KG
    Heart; 2020 May; 106(10):758-764. PubMed ID: 32114516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary Sinus Stent: Could It Help in Refractory Chronic Stable Angina?
    ElMallah W
    Curr Cardiol Rep; 2016 Apr; 18(4):35. PubMed ID: 26922589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.